• November 13, 2019

prismCDX Implements Ultivue’s UltiMapper™ Platform for Standardized, Comprehensive Cancer Tissue Phenotypic Characterization - Odessa American: Business

e-Edition Subscribe

prismCDX Implements Ultivue’s UltiMapper™ Platform for Standardized, Comprehensive Cancer Tissue Phenotypic Characterization

Print
Font Size:
Default font size
Larger font size

Posted: Friday, November 8, 2019 8:35 am

SEOUL, South Korea--(BUSINESS WIRE)--Nov 8, 2019--

prismCDX, a highly specialized contract research organization announced today the selection and adoption of the UltiMapper platform to broaden its offering of translational biomedical research services. The addition of Ultivue’s highly standardized multiplex tissue marker assays enables the identification of critical cellular phenotypes and tissue marker signatures in support of translational and clinical research programs.

“The combination of Ultivue’s next generation tissue marker assays with our platforms for genomic and proteomic analysis provides novel biological insights into the characterization of individual tumor microenvironments,” commented Dong-Jun Bae, CEO with prismCDX. “Such complete tumor profiling and characterization data support our mission at prismCDX to partner with biopharma organizations developing targeted, precision medicine therapies and associated companion diagnostic tests.”

Prior to the launch of those expanded capabilities, prismCDX has received scientific personnel training and certification at both Ultivue’s lab in Cambridge, MA and at its company facilities in Seoul, South Korea.

About prismCDX

prismCDX, based on its innovative technology and scientific expertise, aims to provide solutions for the appropriate immunotherapy for individual patients. Recently, anticancer immunotherapy has helped to cure cancer successfully. However, anticancer immunotherapy requires analytical methods to comprehensively understand the complexity of the cellular level in the tumor microenvironment because treatment prognosis may vary depending on cancer, immune cells, biomarkers, and biological environment. prismCDX’s immune monitoring technology will help clinicians better understand the patient’s immune status and apply the right medication to the individual patient. prismCDX is committed to the growth of global healthcare by developing technologies for diagnosis and companion diagnosis with unique technology.

About Ultivue

By developing a single set of novel, proprietary reagents used both for biomarker discovery (higher content, low throughput) and translational use (lower content, high throughput), Ultivue is connecting the insights gained from research directly into the pathology lab. Ultivue’s UltiMapper™ multiplexed assays applied to tissue biopsy samples enable simultaneous quantitation of multiple biomarkers with sub-cellular spatial resolution and fit completely within traditional IHC workflows. Translational and clinical researchers leverage UltiMapper assays to elucidate complex biology and demonstrate their clinical utility as precision medicine research tools. Ultivue is expanding its UltiMapper assay product portfolio and menu of contract research services to provide a comprehensive set of precision medicine solutions for oncology research and focus in other therapeutic areas.

Ultivue is based in Cambridge, MA. For more information, visit www.ultivue.com

For Research Use Only. Not for use in diagnostic procedures.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191108005007/en/

CONTACT: Ultivue

Louis Levy

+1-617-945-2662

contact@ultivue.com

KEYWORD: SOUTH KOREA UNITED STATES NORTH AMERICA ASIA PACIFIC MASSACHUSETTS

INDUSTRY KEYWORD: SCIENCE SOFTWARE BIOTECHNOLOGY RESEARCH INTERNET ONCOLOGY HEALTH TECHNOLOGY

SOURCE: Ultivue

Copyright Business Wire 2019.

PUB: 11/08/2019 09:35 AM/DISC: 11/08/2019 09:35 AM

http://www.businesswire.com/news/home/20191108005007/en

© 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Sunny
40°
Humidity: 47%
Winds: S at 13mph
Feels Like: 32°

Your Extended Forecast

Tomorrow

weather
High 56°/Low 33°
Mix of sun and clouds. Highs in the mid 50s and lows in the low 30s.

thursday

weather
High 54°/Low 31°
Mainly sunny. Highs in the mid 50s and lows in the low 30s.

friday

weather
High 63°/Low 37°
Abundant sunshine. Highs in the low 60s and lows in the upper 30s.
Online Features

Pet Central

pets

Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>

Fitness

Fitness

Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>

Crosswords

Crosswords

Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>

Sudoku

Sudoku

Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>




  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7314 to sign up today.